UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Cash flows from operating activities:
Net (loss) income	$ (17,008)	$ 69,063
(Loss) income from discontinued operations, net of income taxes	(1,221)	75,379
Loss from continuing operations, net of income taxes	(15,787)	(6,316)
Adjustments to reconcile loss from continuing operations, net of income taxes to net cash provided by (used in) operating activities:
Depreciation	5,029	3,981
Amortization of intangibles	3,792	1,757
Amortization of deferred financing costs	722	576
Change in deferred income tax	1,023	1,404
Compensation under stock-based compensation plans	5,833	2,711
Loss on disposal of fixed assets	(16)	45
Equity in net loss of unconsolidated affiliate	661	0
Changes in assets and liabilities, net of amounts acquired in acquisitions:
Receivables, net of bad debt expense	(15,141)	78,925
Inventory	10,097	(3,104)
Prepaid expenses and other assets	1,318	4,769
Accounts payable	6,219	(50,313)
Claims payable	(3,564)	(860)
Amounts due to plan sponsors	(7,893)	462
Accrued expenses and other liabilities	(13,129)	8,797
Net cash (used in) provided by operating activities from continuing operations	(20,836)	42,834
Net cash (used in) operating activities from discontinued operations	(1,221)	(21,195)
Net cash (used in) provided by operating activities	(22,057)	21,639
Cash flows from investing activities:
Purchases of property and equipment, net	(11,014)	(3,682)
Proceeds from sales of property and equipment	234	0
Cash consideration paid for acquisitions, net of cash acquired	(72,921)	(466)
Net cash proceeds from sale of unconsolidated affiliate	8,509	0
Cash advances to unconsolidated affiliate	(2,348)	0
Cash consideration paid to DS Pharmacy	0	(2,935)
Cash consideration paid for unconsolidated affiliate, net of cash acquired	0	(7,100)
Net cash used in investing activities from continuing operations	(77,540)	(14,183)
Net cash provided by investing activities from discontinued operations	0	161,499
Net cash used in investing activities	(77,540)	147,316
Cash flows from financing activities:
Proceeds from public stock offering	118,570	0
Borrowings on line of credit	351,859	848,633
Repayments on line of credit	(351,859)	(882,455)
Repayments of capital leases	(884)	(2,211)
Net proceeds from exercise of common stock purchase warrants	399	0
Net proceeds from exercise of employee stock compensation plans	1,052	5,675
Surrender of stock to satisfy minimum tax withholding	0	(174)
Net cash provided by (used in) financing activities	119,137	(30,532)
Net change in cash and cash equivalents	19,540	138,423
Cash and cash equivalents - beginning of period	62,101	0
Cash and cash equivalents - end of period	81,641	138,423
DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid during the period for interest	12,327	13,641
Cash paid during the period for income taxes	235	313
DISCLOSURE OF NON-CASH TRANSACTIONS:
Capital lease obligations incurred to acquire property and equipment	$ 0	$ 20